Unknown Causes of Kidney Disease Project: American Kidney Fund Convenes Working Groups to Advance Kidney Disease Diagnoses
FOR IMMEDIATE RELEASE
ROCKVILLE, Md. (December 7, 2021) —The American Kidney Fund (AKF) yesterday held a working session summit to advance the path forward toward uncovering the unknown causes of kidney disease. The working session was the latest convening of AKF’s Unknown Causes of Kidney Disease (UCKD) Project, which brings together thought leaders from across the renal community to address four areas that are critical to improving diagnosis and treatment of kidney disease.
“Too many patients fall into late-stage kidney disease or kidney failure, without a clear understanding of why. This can have dire consequences, such as delayed treatment, additional comorbidities and even the loss of a transplanted kidney,” said LaVarne A. Burton, AKF President and CEO. “We are working to bring together a thoughtful, dedicated collaboration among the kidney care community, resulting in steady progress toward making systematic changes that will help reduce the number of patients unaware of the origins of their kidney disease.”
During the summit, the UCKD Project’s three implementation groups discussed key goals, current progress, anticipated barriers and next steps on:
1. Public policy: Ensuring equitable insurance coverage for patients seeking an accurate diagnosis, including policies that increase genetic testing coverage for kidney disease.
2. Patient and caregiver empowerment: Creating a suite of resources and tools to empower patients to work effectively with their clinicians to secure an accurate diagnosis.
3. Health care professional awareness and education: Addressing knowledge gaps among clinicians, beginning with conducting research with primary care physicians, nephrologists, urologists, endocrinologists, nurse practitioners and physician assistants.
“Sanofi Genzyme has a long-standing commitment to improving the lives of people living with rare renal diseases, said Duane Clark, General Manager, US Rare Diseases, Sanofi Genzyme. “As part of that effort, we are proud to be an ongoing supporter of the important work of the American Kidney Fund and the Unknown Causes of Kidney Disease project, including sponsorship of the Dec. 6 Summit. We know that many people enter late-stage kidney failure without knowing the cause of their disease. The UCKD Summit offers a unique opportunity to bring a wide variety of stakeholders to the table to tackle the real problems in diagnosis and develop action plans, with the common hope of bringing solutions forward that benefit patients living with chronic kidney disease.”
The UCKD Project is supported by Title Sponsor Sanofi Genzyme, Leadership Sponsors Natera and Vertex Pharmaceuticals, Inc. and Champion Sponsors Alexion Pharmaceuticals, Otsuka America Pharmaceutical, Inc. and Travere Therapeutics.
Participants in yesterday’s summit included Alexion Pharmaceuticals, Alport Syndrome Foundation, Fabry Support and Information Group, Natera, National Minority Quality Forum, National Organization for Rare Disorders, National Society of Genetic Counselors, NephCure Kidney International, Otsuka America Pharmaceutical, Inc., Renal Physicians Association, Sanofi Genzyme, Travere Therapeutics and Vertex Pharmaceuticals, Inc.
About the American Kidney Fund
As the nation’s leading independent nonprofit working on behalf of the 37 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling the nation’s low-income dialysis and transplant patients to access lifesaving medical care. AKF holds the highest ratings from the nation’s charity watchdog groups, including Charity Navigator, which includes AKF on its “top 10” list of nonprofits with the longest track records of outstanding stewardship of the donated dollar, and GuideStar, which has awarded AKF its Platinum Seal of Transparency.
For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter and Instagram.